Despite notable progresses in the past few years, and, in particular, the advent of first- and second-generation tyrosine kinase inhibitors (TKI), the treatment of adult BCR-ABL1 acute lymphoblastic leukemia (ALL) patients still remains an unsolved problem. In fact, though chemotherapy (CHT) and TKI are effective for inducing complete remission (CR), durable responses and possibly cure seem be achievable, at present, with stem cell transplantation only. We describe a unique case of BCR-ABL1þ ALL, relapsed after CHT, autologous stem cell transplantation (ASCT), imatinib and dasatinib courses, successfully treated with a combination of dasatinib and a-interferon (a-IFN).

Visani G, Piccaluga P, Malagola M, Isidori A. (2009). Efficacy of dasatinib in conjunction with alpha-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia. LEUKEMIA, 23(9), 1687-1688 [10.1038/leu.2009.96].

Efficacy of dasatinib in conjunction with alpha-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia.

PICCALUGA, PIER PAOLO;
2009

Abstract

Despite notable progresses in the past few years, and, in particular, the advent of first- and second-generation tyrosine kinase inhibitors (TKI), the treatment of adult BCR-ABL1 acute lymphoblastic leukemia (ALL) patients still remains an unsolved problem. In fact, though chemotherapy (CHT) and TKI are effective for inducing complete remission (CR), durable responses and possibly cure seem be achievable, at present, with stem cell transplantation only. We describe a unique case of BCR-ABL1þ ALL, relapsed after CHT, autologous stem cell transplantation (ASCT), imatinib and dasatinib courses, successfully treated with a combination of dasatinib and a-interferon (a-IFN).
2009
Visani G, Piccaluga P, Malagola M, Isidori A. (2009). Efficacy of dasatinib in conjunction with alpha-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia. LEUKEMIA, 23(9), 1687-1688 [10.1038/leu.2009.96].
Visani G; Piccaluga P; Malagola M; Isidori A.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/84325
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact